95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.49%
Revenue growth under 50% of FSM's 16.14%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
1.48%
Gross profit growth under 50% of FSM's 25.80%. Michael Burry would be concerned about a severe competitive disadvantage.
0.13%
EBIT growth below 50% of FSM's 276.84%. Michael Burry would suspect deeper competitive or cost structure issues.
0.13%
Operating income growth under 50% of FSM's 276.84%. Michael Burry would be concerned about deeper cost or sales issues.
-16.66%
Negative net income growth while FSM stands at 476.75%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-23.08%
Negative EPS growth while FSM is at 488.16%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-18.18%
Negative diluted EPS growth while FSM is at 488.16%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.21%
Share reduction more than 1.5x FSM's 4.58%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.66%
Reduced diluted shares while FSM is at 6.09%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
8.47%
OCF growth under 50% of FSM's 343.83%. Michael Burry might suspect questionable revenue recognition or rising costs.
8.47%
FCF growth under 50% of FSM's 25.82%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
180.75%
10Y CAGR of 180.75% while FSM is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
89.12%
5Y CAGR of 89.12% while FSM is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
92.51%
3Y CAGR of 92.51% while FSM is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
No Data
No Data available this quarter, please select a different quarter.
629.21%
Below 50% of FSM's 3223.28%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
189.53%
3Y OCF/share CAGR under 50% of FSM's 423.39%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
No Data
No Data available this quarter, please select a different quarter.
475.60%
5Y net income/share CAGR above 1.5x FSM's 286.14%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
158.49%
3Y net income/share CAGR 50-75% of FSM's 242.95%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
1024.24%
5Y equity/share CAGR above 1.5x FSM's 582.52%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
261.75%
Below 50% of FSM's 572.44%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-39.98%
Firm’s AR is declining while FSM shows 6.08%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
9.52%
Asset growth above 1.5x FSM's 5.02%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-1.14%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
27.56%
Debt growth far above FSM's 4.01%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-9.92%
We cut SG&A while FSM invests at 3.32%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.